1. Type 1 neovascularization may confer resistance to geographic atrophy amongst eyes treated for neovascular age-related macular degeneration Gavazi, Elona; Balaratnasingam, Chandrakumar; Freund, K. Bailey; Lee, Winston 2015 Articles InjectionsNeovascularizationRetinal degenerationOphthalmology